GXD_InBioTechHell
Posted - 1 day ago
$LRMR fuck it I’m out
WarrenPsnik
Posted - 03/28/24
$LRMR Added here ...
Primitivetablemaker
Posted - 1 month ago
$LRMR i put more money on this today.
kubota2323
Posted - 1 month ago
$LRMR adding.
Stocks4thought
Posted - 1 month ago
$LRMR Lamont Larimar Sanford back at the junkyard#############$$$$$$$
Primitivetablemaker
Posted - 1 month ago
$LRMR in.
DonCorleone77
Posted - 1 month ago
$LRMR 2 of 2 - Larimar Therapeutics provides update on nomlabofusp development ....cohort of the Phase 2 study, as well as available data from the 25 mg dose in the OLE study will be submitted for FDA review due to continued partial clinical hold. Ben-Maimon continued, "On the regulatory front, we are continuing discussions with the FDA on the potential use of frataxin as a novel surrogate endpoint to support accelerated approval. We are also beginning to plan for a global double-blind placebo-controlled confirmatory study expected to be initiated prior to a potential BLA submission. The BLA submission is targeted for the second half of 2025. We believe our clinical datasets supporting nomlabofusp's differentiated mechanism of action, coupled with our strengthened balance sheet and expected runway into 2026, strongly position us for execution of our upcoming pivotal milestones designed to help address the urgent unmet needs of the FA community."
DonCorleone77
Posted - 1 month ago
$LRMR 1 of 2 - Larimar Therapeutics provides update on nomlabofusp development In March, the first patient in the OLE study evaluating daily subcutaneous injections of 25 mg of nomlabofusp self-administered or administered by a caregiver was dosed. Participants who completed treatment in the Phase 2 dose exploration trial, or who previously completed a prior clinical trial of nomlabofusp, are potentially eligible to screen for the OLE study. The OLE study will evaluate the safety and tolerability, pharmacokinetics, and frataxin levels in peripheral tissues as well as other exploratory pharmacodynamic markers following long-term subcutaneous administration of nomlabofusp. Clinical assessments collected during the trial will be compared to data from a matched control arm derived from participants in the Friedreich's Ataxia Clinical Outcome Measures Study, or FACOMS, database. Interim data is expected in Q4 2024. To potentially escalate dose in the OLE study, data from the 50 mg....
DonCorleone77
Posted - 1 month ago
$LRMR Larimar Therapeutics reports Q4 EPS (30c), consensus (25c) As of December 31, 2023, the Company had cash, cash equivalents and marketable securities totaling $86.8 million. "This year we made tremendous progress across key clinical and regulatory milestones for our nomlabofusp program. We were thrilled to recently report positive top-line data and successful completion of our Phase 2 dose exploration study. Nomlabofusp was generally well-tolerated and demonstrated dose-dependent increases in skin and buccal cell frataxin levels. Importantly, skin frataxin levels as a percentage of levels in healthy volunteers more than doubled in all patients after 14 days of daily treatment with 50 mg. The clear dose-response and the magnitude of increase in tissue frataxin levels further reinforces the therapeutic potential of nomlabofusp to address frataxin deficiency, the known root cause of disease in patients with Friedreich's ataxia (FA)," said Carole Ben-Maimon....
Stock_Titan
Posted - 1 month ago
$LRMR Larimar Therapeutics Reports Fourth Quarter and Full Year 2023 Operating and Financial Results and Provides Update on Nomlabofusp Development
https://www.stocktitan.net/news/LRMR/larimar-therapeutics-reports-fourth-quarter-and-full-year-2023-rkj8x05l00rr.html
DonCorleone77
Posted - 1 month ago
$LRMR Larimar Therapeutics doses first patient in nomlabofusp study Larimar Therapeutics announced dosing of the first patient in an open label extension, or OLE, study evaluating 25 mg daily subcutaneous injections of nomlabofusp in participants with Friedreich's ataxia, or FA. Nomlabofusp is a novel protein replacement therapy designed to address the root cause of Friedreich's ataxia by delivering frataxin to mitochondria.
Stock_Titan
Posted - 1 month ago
$LRMR Larimar Therapeutics Announces the Dosing of the First Patient in Long-term Open Label Extension Study for Nomlabofusp in Patients with Friedreich’s Ataxia https://www.stocktitan.net/news/LRMR/larimar-therapeutics-announces-the-dosing-of-the-first-patient-in-6tsil5y9lxlw.html
Stock_Titan
Posted - 1 month ago
$LRMR Larimar Therapeutics to Present at the Leerink Partners Global Biopharma Conference
https://www.stocktitan.net/news/LRMR/larimar-therapeutics-to-present-at-the-leerink-partners-global-9xuap0sytu3m.html
HedgeFollow
Posted - 2 months ago
Top 5 Largest Insider Buys this week are on: $FLME, $TNYA, $PLCE, $LRMR and $AREN Pay attention to when company Insiders make large purchases in their own companies. Source: https://hedgefollow.com/largest-insider-buys.php
Tommy_Two_Toes
Posted - 2 months ago
$LRMR $38 mil insider buy Director
Stock_Titan
Posted - 2 months ago
$LRMR Larimar Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
https://www.stocktitan.net/news/LRMR/larimar-therapeutics-announces-closing-of-underwritten-public-jhvfqu7x2r2c.html
insiderbuyingselling
Posted - 2 months ago
$LRMR new insider buying: 4290617 shares. http://insiderbuyingselling.com/?t=LRMR
SadyK189
Posted - 2 months ago
$LRMR Initially Alerted at 7.76. Still looking strong on daily chart. Next key level to test is 14.3 - 15. It may take sometime though.
nevermind889
Posted - 2 months ago
$LRMR This is unstoppable. Wish I got in at 5.01 when it was on my radar in mid January!
johnnyutah007
Posted - 2 months ago
$LRMR 💪
Prized_Possessions
Posted - 2 months ago
$LRMR public offering in the 8s….very 2020 of this stock to keep grinding up…. Logic and conditioning made me miss out on move up - but.. def aint short … so much silly stuff.
LLYW
Posted - 2 months ago
$LRMR how this is still up this high is beyond me w that recent $8 200 million public offering . Could keep going a bit but will come down quick when it does
ronaldo7
Posted - 2 months ago
$DAL $FULC $LRMR Thank God for these 3 Stocks, I made a fortune since November 2023, especially with $LRMR
Stocks4thought
Posted - 2 months ago
$PASG $1.40 when they take these hoejoes out a here. All stocks matter $QNCX $SLDB $LRMR
Moonman321
Posted - 2 months ago
$LRMR hyfm
Cgc
Baba
SadyK189
Posted - 2 months ago
$LRMR Price 7.76. My post was "looking strong on daily chart. Key support at 6.5 - 7. Currently at 7.76. Looking good to test next key level at 8.65 - 9.2. Overall, it has potential for $11+" It went till 13.35 today
Stocks4thought
Posted - 2 months ago
$QNCX $1.70 NT $LRMR Quincy Jones- step-child-------------rare disease bird sighting.
Stocks4thought
Posted - 2 months ago
$SLDB $10 shortly that's just the way it is. https://www.youtube.com/watch?v=cOeKidp-iWo&ab_channel=BruceHornsbyVEVO $LRMR sister susan.
Stocks4thought
Posted - 2 months ago
$SLDB Wait for it- gonna do a $LRMR Lamont Sanford$
